GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

48.37USD
31 Jul 2014
Price Change (% chg)

$-0.10 (-0.21%)
Prev Close
$48.47
Open
$48.88
Day's High
$48.88
Day's Low
$48.35
Volume
5,813,541
Avg. Vol
2,911,562
52-wk High
$56.73
52-wk Low
$48.01

GSK

Chart for GSK

About

GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK’s principal pharmaceutical products include medicines in... (more)

Overall

Beta: 0.58
Market Cap (Mil.): $117,072.20
Shares Outstanding (Mil.): 2,424.46
Dividend: 0.65
Yield (%): 5.48

Financials

  GSK Industry Sector
P/E (TTM): 14.74 35.82 36.29
EPS (TTM): 3.29 -- --
ROI: 18.08 18.85 18.13
ROE: 75.85 19.57 18.95
Search Stocks

Despite strains, GlaxoSmithKline dividend seen safe for now

LONDON - GlaxoSmithKline's fat dividend is under strain but Britain's biggest drugmaker is likely to scrape by without cutting payouts as it seeks to compensate investors during a bumpy reshaping of the company.

29 Jul 2014

Despite strains, GlaxoSmithKline dividend seen safe for now

* GSK seen avoiding cut but dividend may flatline - analysts

29 Jul 2014

Shanghai court says trial of GSK-linked investigators set for August 8

SHANGHAI - The public trial of a foreign couple linked to GlaxoSmithKline Plc (GSK) is set for Aug. 8, a Shanghai court said on Tuesday.

29 Jul 2014

Shanghai court says trial of GSK-linked investigators set for Aug 8

SHANGHAI, July 29 - The public trial of a foreign couple linked to GlaxoSmithKline Plc (GSK) is set for Aug. 8, a Shanghai court said on Tuesday.

29 Jul 2014

Banks outperform Britain's FTSE after RBS's bumper results

LONDON, July 25 - British lenders who focus on the domestic market outperformed a slightly negative FTSE 100 index on Friday after strong results from Royal Bank of Scotland and solid economic growth data.

25 Jul 2014

Banks outpace flat UK FTSE after RBS's bumper results

LONDON, July 25 - British lenders who focus on the domestic market outpaced a flat FTSE 100 index on Friday after strong results from Royal Bank of Scotland and solid economic output data.

25 Jul 2014

Exclusive: Allegations of GSK corruption spread to Syria

LONDON - GlaxoSmithKline faces new allegations of corruption, this time in Syria, where the drugmaker and its distributor have been accused of paying bribes to secure business, according to a whistleblower's email reviewed by Reuters.

24 Jul 2014

GSK seeks approval for world's first malaria vaccine

LONDON - GlaxoSmithKline said on Thursday it is applying for regulatory approval for the world's first vaccine against malaria, designed for children in Africa.

24 Jul 2014

UPDATE 2-GSK seeks approval for world's first malaria vaccine

* Mosquito-borne malaria kills over 600,000 people a year

24 Jul 2014

Atox Bio raises $23 million to fund flesh-eating bacteria treatment

TEL AVIV - Israel-based Atox Bio, a developer of therapeutics for severe infections, said on Thursday it has raised $23 million in an investment round led by SR One, the healthcare venture capital fund of GlaxoSmithKline.

24 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks